GW Pharmaceuticals Plc (GWPH)

156.72
0.85 0.55
NASDAQ : Health Technology
Prev Close 155.87
Open 155.90
Day Low/High 155.87 / 161.01
52 Wk Low/High 90.14 / 179.65
Volume 178.69K
Avg Volume 466.80K
Exchange NASDAQ
Shares Outstanding 30.45M
Market Cap 5.25B
EPS -10.60
P/E Ratio N/A
Div & Yield N.A. (N.A)
'Mad Money' Lightning Round: Buy, Buy, Buy Intuit

'Mad Money' Lightning Round: Buy, Buy, Buy Intuit

Cramer says Time Warner is a good stock but you should sell Interoil.

Jim Cramer's 'Mad Money' Recap: Stay Disciplined in This Market

Jim Cramer's 'Mad Money' Recap: Stay Disciplined in This Market

How does Cramer know that investors are getting careless? Because they see takeovers everywhere.

4 Top Stocks in the Growing Medical Marijuana Industry

4 Top Stocks in the Growing Medical Marijuana Industry

Weed has gone from a taboo substance to a multi-billion-dollar bonanza. The growth of the marijuana sector has created opportunities for investors. Here are four to watch.

5 Stocks Set to Soar on Bullish Earnings

5 Stocks Set to Soar on Bullish Earnings

These heavily shorted stocks could get squeezed much higher if they report positive earnings this week.

Making the Right Budding Investment: Medical Versus Recreational Cannabis Companies

Making the Right Budding Investment: Medical Versus Recreational Cannabis Companies

Investors choosing among the hundreds of cannabis businesses are often caught in a conundrum as to whether medical companies are a safer investment compared to recreational businesses.

How to Invest in Nasdaq-Traded Marijuana Stocks and Private Pot Companies

How to Invest in Nasdaq-Traded Marijuana Stocks and Private Pot Companies

Companies are seeking options for mainstream investors to get high gains. Americans can invest in multiple businesses traded publicly on the Nasdaq or take a private investment approach.

These 3 Marijuana-Related Stocks Are Poised for Strong Growth

These 3 Marijuana-Related Stocks Are Poised for Strong Growth

The medical marijuana business should rack up smoking gains. We've pinpointed the three stocks that will benefit the most.

'Mad Money' Lightning Round: Step Into Skechers Long Term

'Mad Money' Lightning Round: Step Into Skechers Long Term

Cramer says to wait on GW Pharmaceuticals but he likes Ashland's fundamentals.

Jim Cramer's 'Mad Money' Recap: We've Won the War Against the Dollar

Jim Cramer's 'Mad Money' Recap: We've Won the War Against the Dollar

Cramer says the Federal Reserve took a 'common sense' approach to interest rates by only taking action when needed.

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of GW Pharmaceuticals Plc Of Class Action And A Lead Plaintiff Deadline Of March 21, 2016

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of GW Pharmaceuticals Plc Of Class Action And A Lead Plaintiff Deadline Of March 21, 2016

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of GW Pharmaceuticals plc ("GW Pharmaceuticals") (NASDAQ: GWPH)...

Why Pot Stock GW Pharmaceuticals Could Go Even Higher in 2016

Why Pot Stock GW Pharmaceuticals Could Go Even Higher in 2016

As the marijuana industry becomes a multibillion-dollar business, shares of cannabinoid drug company GW Pharmaceuticals are getting quite high.

GWPH Momentum Passed Around to Other Pot Stocks

GWPH Momentum Passed Around to Other Pot Stocks

GW Pharmaceuticals saw its stock price surge amid news of a successful Epidiolex clinical trial. But that high also generated buzz across pot stocks at large.

GW Pharma (GWPH) Stock Spiked on Promising Cannabis-Derived Drug, Jim Cramer's Take

GW Pharma (GWPH) Stock Spiked on Promising Cannabis-Derived Drug, Jim Cramer's Take

GW Pharma (GWPH) stock more than doubled in Monday's trading session after its cannabis-derived drug demonstrated positive results.

Jim Cramer -- GW Pharma's Cannabinoid Treatment Could Be the Start

Jim Cramer -- GW Pharma's Cannabinoid Treatment Could Be the Start

GW Pharma's positive Phase 3 results for its Epidiolex drug could have far-reaching implications for other treatments, Cramer says.

Here's Why GW Pharma (GWPH) Stock Is Skyrocketing Today

Here's Why GW Pharma (GWPH) Stock Is Skyrocketing Today

GW Pharma (GWPH) stock has more than doubled in trading on Monday after its cannabis-based drug successfully treated children with severe epilepsy.

GW Pharma Marijuana Drug Cuts Seizure Rate in Pivotal Study

GW Pharma Marijuana Drug Cuts Seizure Rate in Pivotal Study

GW Pharma says it plans to discuss the positive findings from the phase III study with the U.S. Food and Drug Administration regarding a possible approval filing.

SHAREHOLDER ALERT: Law Office Of Brodsky & Smith, LLC Announces Investigation Of GW Pharmaceuticals Plc

SHAREHOLDER ALERT: Law Office Of Brodsky & Smith, LLC Announces Investigation Of GW Pharmaceuticals Plc

Law Office of Brodsky & Smith, LLC announces an investigation of GW Pharmaceuticals plc ("GW Pharmaceuticals" or the "Company") (Nasdaq: GWPH) for potential violations of federal securities laws and breaches of the GW...

SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Notify Investors Of Class Action Lawsuit Involving GW Pharmaceuticals Plc And A Lead Plaintiff Deadline Of March 21, 2016

SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Notify Investors Of Class Action Lawsuit Involving GW Pharmaceuticals Plc And A Lead Plaintiff Deadline Of March 21, 2016

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased GW Pharmaceuticals plc (Nasdaq: GWPH) securities...

'Mad Money' Lightning Round: Buy, Buy, Buy Bristol-Myers Squibb

'Mad Money' Lightning Round: Buy, Buy, Buy Bristol-Myers Squibb

Cramer still believes in Fitbit's long-term outlook but said Amicus Therapeutics is too speculative for him.

Jim Cramer's 'Mad Money' Recap: Commodities Are Healing, so Are Markets

Jim Cramer's 'Mad Money' Recap: Commodities Are Healing, so Are Markets

While many bears are dismissing the rally in commodity stocks as simple short covering, Cramer says there's actually a lot more in play.

Oversold Conditions For GW Pharmaceuticals (GWPH)

Oversold Conditions For GW Pharmaceuticals (GWPH)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of GW Pharmaceuticals Plc Of Class Action And A Lead Plaintiff Deadline Of March 21, 2016

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of GW Pharmaceuticals Plc Of Class Action And A Lead Plaintiff Deadline Of March 21, 2016

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of GW Pharmaceuticals plc ("GW Pharmaceuticals") (NASDAQ: GWPH)...

IMPORTANT SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In GW Pharmaceuticals PLC To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

IMPORTANT SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In GW Pharmaceuticals PLC To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of...